Home » Topics » BioWorld Science

BioWorld Science
RSS

Bionomics presents Nav1.7 channel blockers

Nov. 29, 2019

New anticancer compounds discovered at Zymeworks

Nov. 29, 2019

Incyte patents PD-1/PD-L1 interaction inhibitors

Nov. 29, 2019

Array BioPharma, Mirati Therapeutics describe new G12C-mutant GTPase KRAS inhibitors

Nov. 29, 2019

Prestige Biopharma initiates phase III study of proposed biosimilar HD-204

Nov. 29, 2019

First-in-human study of 89Zr-DFO-REGN-3504 for imaging PD-L1 tumors

Nov. 29, 2019

Enrollment ongoing in phase II study of ciprofloxacin/celecoxib fixed-dose combination

Nov. 29, 2019

KY-1043 demonstrates potent antitumor activity in vitro and in vivo

Nov. 29, 2019

Roche presents phase III data for atezolizumab plus bevacizumab in HCC

Nov. 29, 2019

G. mellonella as a promising in vivo model for assessing the pathogenesis of GBS

Nov. 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...